BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7033849)

  • 1. Indomethacin-induced azotaemia and hyperkalaemia: a case study.
    Nicholls MG; Espiner EA
    N Z Med J; 1981 Nov; 94(696):377-9. PubMed ID: 7033849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperkalemia associated with indomethacin.
    Goldszer RC; Coodley EL; Rosner MJ; Simons WM; Schwartz AB
    Arch Intern Med; 1981 May; 141(6):802-4. PubMed ID: 7016059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute renal failure and hyperkalaemia associated with cyclooxygenase-2 inhibitors.
    Braden GL; O'Shea MH; Mulhern JG; Germain MJ
    Nephrol Dial Transplant; 2004 May; 19(5):1149-53. PubMed ID: 14993496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism.
    Tan SY; Shapiro R; Franco R; Stockard H; Mulrow PJ
    Ann Intern Med; 1979 May; 90(5):783-5. PubMed ID: 434681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin-induced hyperkalemia in three patients with gouty arthritis.
    Findling JW; Beckstrom D; Rawsthorne L; Kozin F; Itskovitz H
    JAMA; 1980 Sep; 244(10):1127-8. PubMed ID: 7411769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible acute renal insufficiency and hyperkalemia following indomethacin therapy.
    Galler M; Folkert VW; Schlondorff D
    JAMA; 1981 Jul; 246(2):154-5. PubMed ID: 7017180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyporeninemic hypoaldosteronism syndrome caused by indomethacin].
    Kutyrina IM; Androsova SO; Li Chun Khi
    Klin Med (Mosk); 1980 May; 58(5):27-30. PubMed ID: 6991804
    [No Abstract]   [Full Text] [Related]  

  • 8. Indomethacin-induced inhibition of prostaglandin with hyperkalemia.
    MacCarthy EP; Stokes GS
    Ann Intern Med; 1979 Sep; 91(3):500. PubMed ID: 475200
    [No Abstract]   [Full Text] [Related]  

  • 9. Indomethacin- and Moduretic--induced hyperkalemia.
    Mor R; Pitlik S; Rosenfeld JB
    Isr J Med Sci; 1983 Jun; 19(6):535-7. PubMed ID: 6862860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of glucose-induced hyperkalemia by sodium restriction in "normaldosteronemic" diabetes mellitus.
    Radó JP
    Endokrinologie; 1981 Dec; 78(2-3):244-52. PubMed ID: 7037374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium handling by the kidney. Hyperkalaemia.
    Barratt LJ
    Aust N Z J Med; 1981; 11(Suppl 1):16-22. PubMed ID: 7020667
    [No Abstract]   [Full Text] [Related]  

  • 12. New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia.
    Cruz CS; Cruz LS; Domingues GS; Souza CA
    Expert Opin Drug Saf; 2005 Jul; 4(4):677-88. PubMed ID: 16011447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coadministration of estradiol/drospirenone and indomethacin does not cause hyperkalemia in healthy postmenopausal women: a randomized open-label crossover study.
    Schütt B; Kunz M; Blode H
    J Clin Pharmacol; 2007 Jun; 47(6):774-81. PubMed ID: 17463217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence of ACE inhibitors on urinary electrolyte secretion and the response to transitory hypovolemia in chronic heart failure].
    Marenzi G; Lauri G; Assanelli E; Grazi M; Guazzi M; Berna G; Salvioni A; Agostoni P
    Cardiologia; 1997 Dec; 42(12):1277-83. PubMed ID: 9534323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selective hypoaldosteronism with hyperkalemia. Clinical and physiopathological study of 22 cases with hypo- or hyperreninemia].
    Paladini G; Mazzanti G; Fabiani MG; Zulli L; Parma A
    Minerva Med; 1988 Nov; 79(11):947-56. PubMed ID: 3059234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW; Won YW; Yi JH; Kim HJ
    Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose-induced hyperkalemia in normaldosteronemic diabetes associated with hyperthyroidism.
    Radó JP
    Endokrinologie; 1981 Dec; 78(2-3):239-43. PubMed ID: 7037373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression.
    Heering PJ; Kurschat C; Vo DT; Klein-Vehne N; Fehsel K; Ivens K
    Clin Transplant; 2004 Apr; 18(2):186-92. PubMed ID: 15016134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of Bartter syndrome with indomethacin].
    Ploier R; Tulzer W; Fink M; Bohrn E
    Padiatr Padol; 1981; 16(1):81-92. PubMed ID: 7017552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indomethacin-induced hyperkalaemia.
    MacCarthy EP; Frost GW; Strokes GS
    Med J Aust; 1979 Jun; 1(12):550. PubMed ID: 470726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.